Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1947 4
1948 4
1949 2
1950 4
1951 12
1952 5
1953 5
1954 10
1955 7
1956 1
1957 9
1958 3
1959 3
1960 8
1961 12
1962 5
1963 8
1964 8
1965 4
1966 3
1967 1
1968 1
1969 2
1970 2
1971 4
1972 2
1973 5
1974 3
1975 6
1976 18
1977 43
1978 47
1979 38
1980 44
1981 48
1982 39
1983 39
1984 35
1985 56
1986 67
1987 54
1988 48
1989 69
1990 77
1991 112
1992 105
1993 123
1994 93
1995 117
1996 110
1997 107
1998 114
1999 141
2000 141
2001 136
2002 153
2003 137
2004 127
2005 168
2006 175
2007 170
2008 161
2009 208
2010 201
2011 268
2012 250
2013 253
2014 245
2015 240
2016 248
2017 247
2018 281
2019 333
2020 353
2021 390
2022 305
2023 338
2024 341
2025 365
2026 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,461 results

Results by year

Filters applied: . Clear all
Page 1
Dravet syndrome.
Lagae L. Lagae L. Curr Opin Neurol. 2021 Apr 1;34(2):213-218. doi: 10.1097/WCO.0000000000000902. Curr Opin Neurol. 2021. PMID: 33395108 Review.
PURPOSE OF REVIEW: This review will illustrate the electroclinical description of Dravet syndrome, highlighting the difficulty to understand the correlation between the SCN1A mutation and clinical characteristics, including the frequent comorbidities. ...Genetic tre …
PURPOSE OF REVIEW: This review will illustrate the electroclinical description of Dravet syndrome, highlighting the difficulty …
Genetic therapeutic advancements for Dravet Syndrome.
Chilcott E, Díaz JA, Bertram C, Berti M, Karda R. Chilcott E, et al. Epilepsy Behav. 2022 Jul;132:108741. doi: 10.1016/j.yebeh.2022.108741. Epub 2022 May 30. Epilepsy Behav. 2022. PMID: 35653814 Free article. Review.
Dravet Syndrome is a genetic epileptic syndrome characterized by severe and intractable seizures associated with cognitive, motor, and behavioral impairments. ...In this review, we summarize our current knowledge of novel genetic therapies that are currently …
Dravet Syndrome is a genetic epileptic syndrome characterized by severe and intractable seizures associated with cognit …
Dravet syndrome: Advances in etiology, clinical presentation, and treatment.
He Z, Li Y, Zhao X, Li B. He Z, et al. Epilepsy Res. 2022 Dec;188:107041. doi: 10.1016/j.eplepsyres.2022.107041. Epub 2022 Oct 29. Epilepsy Res. 2022. PMID: 36368227 Review.
Dravet syndrome (DS) is a form of genetic refractory epilepsy. More than 80 % of DS patients carry pathogenic SCN1A mutations, and this percentage is actually higher due to false-negative results in gene testing. ...Most DS patients experience prolonged, hemiclonic …
Dravet syndrome (DS) is a form of genetic refractory epilepsy. More than 80 % of DS patients carry pathogenic SCN1A mutations, …
International consensus on diagnosis and management of Dravet syndrome.
Wirrell EC, Hood V, Knupp KG, Meskis MA, Nabbout R, Scheffer IE, Wilmshurst J, Sullivan J. Wirrell EC, et al. Epilepsia. 2022 Jul;63(7):1761-1777. doi: 10.1111/epi.17274. Epub 2022 May 12. Epilepsia. 2022. PMID: 35490361 Free PMC article.
OBJECTIVE: This study was undertaken to gain consensus from experienced physicians and caregivers regarding optimal diagnosis and management of Dravet syndrome (DS), in the context of recently approved, DS-specific therapies and emerging disease-modifying treatments …
OBJECTIVE: This study was undertaken to gain consensus from experienced physicians and caregivers regarding optimal diagnosis and management …
Dravet Syndrome: Don't Hesitate, Just Vaccinate!
Nickels KC, Wirrell EC. Nickels KC, et al. Neurology. 2023 Jan 24;100(4):171-173. doi: 10.1212/WNL.0000000000201531. Epub 2022 Nov 2. Neurology. 2023. PMID: 36323523 No abstract available.
Defining Dravet syndrome: An essential pre-requisite for precision medicine trials.
Li W, Schneider AL, Scheffer IE. Li W, et al. Epilepsia. 2021 Sep;62(9):2205-2217. doi: 10.1111/epi.17015. Epub 2021 Aug 2. Epilepsia. 2021. PMID: 34338318 Free PMC article.
Patients with SCN1A pathogenic variants were reviewed and only those with Dravet syndrome were included. Clinical data, including seizure and developmental course, were analyzed in all patients with SCN1A-Dravet syndrome. ...SIGNIFICANCE: An evidence-b …
Patients with SCN1A pathogenic variants were reviewed and only those with Dravet syndrome were included. Clinical data, includ …
Dravet Syndrome: A Review of Current Management.
Wheless JW, Fulton SP, Mudigoudar BD. Wheless JW, et al. Pediatr Neurol. 2020 Jun;107:28-40. doi: 10.1016/j.pediatrneurol.2020.01.005. Epub 2020 Jan 31. Pediatr Neurol. 2020. PMID: 32165031 Review.
Dravet syndrome is a debilitating epileptic encephalopathy of childhood with few treatment options available in the United States before 2018. ...Three new medicines-stiripentol, cannabidiol, and fenfluramine-have documented efficacy and safety as adjunctive therapi …
Dravet syndrome is a debilitating epileptic encephalopathy of childhood with few treatment options available in the United Sta …
Stiripentol (Diacomit) for Dravet syndrome.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2021 Mar 22;63(1620):e48-e50. Med Lett Drugs Ther. 2021. PMID: 33976090 Review. No abstract available.
Dravet syndrome history.
Dravet C. Dravet C. Dev Med Child Neurol. 2011 Apr;53 Suppl 2:1-6. doi: 10.1111/j.1469-8749.2011.03964.x. Dev Med Child Neurol. 2011. PMID: 21504424 Free article. Review.
Severe myoclonic epilepsy of infancy (SMEI) is a complex form of epilepsy that was first described in France in 1978. Because the myoclonic component of this epilepsy is not always present and because some variability has been observed in the symptomatology, the nam …
Severe myoclonic epilepsy of infancy (SMEI) is a complex form of epilepsy that was first described in France in 1978. Because the …
Dravet Syndrome: Past, Present, and Future.
Liu YH, Kuo CY, Chou IC, Hsu TR, Lin KL; Society for Neurological Rare Disorders-Taiwan. Liu YH, et al. Acta Neurol Taiwan. 2025 Jul 1;34(3):125-132. doi: 10.4103/ant.ANT-D-25-00005. Epub 2025 Sep 29. Acta Neurol Taiwan. 2025. PMID: 41020456 Review.
Dravet syndrome (DS) is a severe and rare developmental epileptic encephalopathy and genetic epilepsy characterized by the onset of seizures before 1 year of age, typically prolonged generalized tonic-clonic or hemiclonic seizures, specific triggers such as vaccinat …
Dravet syndrome (DS) is a severe and rare developmental epileptic encephalopathy and genetic epilepsy characterized by the ons …
7,461 results